EGM
VRPX

Engineers Gate Manager’s Virpax Pharmaceuticals, Inc. Common Stock VRPX Stock Holding History

Engineers Gate Manager’s Portfolio VRPX Stock Details VRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-47
Closed -$40K – 2427
2021
Q4 		$40K Buy
+47
New +$48.4K ﹤0.01% 1895

Other funds holding VRPX

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Engineers Gate Manager's VRPX Position: Q1 2022 in Review

Engineers Gate Manager sold out of Virpax Pharmaceuticals, Inc. Common Stock (VRPX) in Q1 2022, closing a stake of 47 shares — an estimated $40K sold.

Engineers Gate Manager first reported a position in VRPX in Q4 2021 and held it in 1 quarter. The position peaked at $40K in Q4 2021. 14 funds tracked by Wall St. Rank hold VRPX as of Q1 2022.

  • Engineers Gate Manager reported no remaining Virpax Pharmaceuticals, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Engineers Gate Manager sold 47 Virpax Pharmaceuticals, Inc. Common Stock shares in Q1 2022, an estimated $40K.
  • Engineers Gate Manager first reported a position in Virpax Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Engineers Gate Manager's Virpax Pharmaceuticals, Inc. Common Stock position peaked at $40K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Virpax Pharmaceuticals, Inc. Common Stock as of Q1 2022.

Based on Engineers Gate Manager's 13F filing for Q1 2022, filed 16 May 2022.